Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jianmeng Chen
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
ORCID:
0009-0004-7585-0701
Observed ORCID:
0009-0004-7585-0701
OpenAlex ID:
A5074233366
Approval of Mycophenolate Mofetil for Prophylaxis of Organ Rejection in Pediatric Recipients of Heart or Liver Transplants: A Regulatory Perspective
2024
·
Amer Al‐Khouja
, Nadia Chaudhri
, et al.
·
Clinical Pharmacology & Therapeutics
·
8
Model‐Informed Drug Development‐Based Approval of Intravenous Secukinumab for the Treatment of Adult Patients with Active Psoriatic Arthritis, Active Ankylosing Spondylitis, and Active Non‐Radiographic Axial Spondyloarthritis
2024
·
Dipak S. Pisal
, Yangbing Li
, et al.
·
Clinical Pharmacology & Therapeutics
·
6
PDF
Approval of Upadacitinib in Pediatric Patients with Active Polyarticular Juvenile Idiopathic Arthritis or Active Psoriatic Arthritis: A Regulatory Perspective
2025
·
Lei He
, Da Zhang
, et al.
·
The Journal of Clinical Pharmacology
·
5
PDF
A Meta‐Analysis of the Safety and Immunogenicity of Pharmacokinetic Similarity Studies and Comparative Clinical Studies
2024
·
Ping Ji
, Sarah J. Schrieber
, et al.
·
The Journal of Clinical Pharmacology
·
4
Comparison of Analysis of Covariance and Analysis of Variance in Pharmacokinetic Similarity Studies
2025
·
Brett A. Martini
, Ping Ji
, et al.
·
The Journal of Clinical Pharmacology
·
1
PDF
Show more works
View as search
Works count:
5
Citation count:
24
H-index:
4
I10-index:
Year
Topic
Type